Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action This viewpoint paper addresses new priorities for drug susceptibility testing (DST) and surveillance now that new tuberculosis drug regimens are likely to be introduced in the coming years. It is a summary...
For Whom the Bell Tolls: Isoniazid Preventive Therapy and Tuberculosis Drug Resistance In a Focus paper, Frank Cobelens dicusses the outcomes and implications of a mathematical modeling study by Mills at al in the same issue. Mills' study explores the long-term population-level impact of large-scale isoniazid...
The narrative of the symposium 'HIV Drug Resistance and the Future of Antiretroviral Treatment in sub-Saharan Africa' is now online! Please click here to view the narrative ...
Long-distance truck drivers are at risk of acquiring and transmitting HIV and have suboptimal access to care. New HIV prevention strategies using antiretroviral drugs to reduce transmission risk (early antiretroviral therapy (ART) at CD4 count >350 cells/μL) have shown efficacy in clinical trials. Demonstration projects are...
PASER collaborates in the development of a support tool for physicians in resource-limited countries to predict ART response without the need for HIV resistance testing The PASER network has collaborated in a promising HIV drug resistance computational modelling study. This study aims to develop a support...
The presentations of the Symposium 'HIV Drug Resistance and the Future of Antiretroviral Treatment in sub-Saharan Africa' held on 6 February 2013 are now online! View..> ...